Our findings demonstrate that BATF3 is required to maintain a healthy intestinal barrier and prevent the development of intestinal dysbiosis and chronic low-grade inflammation that contributes to the development of metabolic syndrome. Here, BATF3 is linked to metabolic syndrome.